Table of Contents

The upcoming bankruptcy hearing on February 18, 2025, will be crucial in determining whether Johnson & Johnson’s proposed $10 billion bankruptcy plan can move forward. The company is using a controversial legal strategy called the Texas two-step, which aims to limit its liability for cancer claims while protecting its financial interests. 

Some victims support this approach for quicker compensation, while others argue it unfairly prioritizes the company’s needs over justice for those harmed. The hearing follows a significant Supreme Court ruling in Purdue Pharma’s bankruptcy, which could impact the legality of J&J’s plan. This case may lead to justice for many victims or result in further delays, with appeals potentially extending the legal battle.

Enter a 10-digit phone number with digits only (e.g., 1234567890)

By clicking the ‘Get a Free Review’ button, I hereby grant consent to be contacted at the phone number above for marketing purposes by Tort Advisor and its partners. I understand this may include an automated calling system, artificial voice, pre-recorded message, or an SMS text message. I consent even if my phone number provided is registered on the Federal or State ‘Do Not Call Registry’. I acknowledge that standard message and data rates may apply. Message frequency varies. Text HELP for help. Text STOP to cancel. Clicking ‘Get a Free Review’ constitutes my electronic signature for authorization to be contacted and my agreement to the Terms and Conditions and [Privacy Policy]. This authorization is not required to qualify for, purchase goods, or receive services.

Partners Off-Canvas (Hidden)